long term use of glp 1 agonists Psychological and behavioral effects GLP-1 and GIP in weight loss: a comprehensive review | Journal of Diabetes & Metabolic Disorders Current Insights, Advantages and Challenges

As our earlier article showed, the possibilities range across any number of body systems, touching Alzheimers disease, fatty liver disease, arthritis, pain relief and even certain types of cancer

It is a microbiome-based approach to supporting one of the body most studied metabolic hormones

Access to these drugs is likely to exacerbate inequities, added on to the lack of diversity of the people assessed in the trial

DOI: 10.1093/carcin/bgr001 Guasch-Ferre, M., Li, Y., Willett, W.C., et al

When GLP-1s became popular for weight loss, the market saw a shortage of them, which is why the FDA allowed compounding pharmacies to begin formulating non-branded, compounded versions of them

Prioritizing health and wellness during this journey can lead to a more positive and empowered approach to managing diabetes and achieving weight loss goals